Moderna, Inc.MRNANASDAQ
Loading
SG&A Expense Growth TrendStable
Percentile Rank60
3Y CAGR-24.7%
5Y CAGR-25.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-24.7%/yr
Quarterly compound
5Y CAGR
-25.4%/yr
Consistent
Percentile
P60
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 14.93% |
| Q3 2025 | 16.52% |
| Q2 2025 | 8.49% |
| Q1 2025 | -39.60% |
| Q4 2024 | 24.91% |
| Q3 2024 | 4.85% |
| Q2 2024 | -2.19% |
| Q1 2024 | -41.70% |
| Q4 2023 | 6.33% |
| Q3 2023 | 33.13% |
| Q2 2023 | 8.85% |
| Q1 2023 | -18.67% |
| Q4 2022 | 34.89% |
| Q3 2022 | 31.75% |
| Q2 2022 | -21.27% |
| Q1 2022 | 33.33% |
| Q4 2021 | 19.64% |
| Q3 2021 | 38.84% |
| Q2 2021 | 57.14% |
| Q1 2021 | -2.52% |
| Q4 2020 | 64.56% |
| Q3 2020 | 29.73% |
| Q2 2020 | 53.44% |
| Q1 2020 | -5.90% |
| Q4 2019 | -9.09% |
| Q3 2019 | -1.17% |
| Q2 2019 | 4.54% |
| Q1 2019 | -28.25% |
| Q4 2018 | 105.25% |
| Q3 2018 | -13.38% |
| Q2 2018 | 31.07% |
| Q1 2018 | 2.59% |
| Q4 2017 | -4.93% |
| Q3 2017 | 4.28% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |